In one paragraphArticle in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors at 4 institutions in 2 countries.
María CastañoHaemostasis, Thrombosis, Arteriosclerosis and Vascular Biology Research Group, Medical Research Institute Hospital La Fe, 46026 Valencia, Spain.
Eva González-CantóResearch Laboratory in Biomarkers in Reproduction, Gynaecology, and Obstetrics, Research Foundation of the General University Hospital of Valencia, 46014 Valencia, Spain.ORCID 0000-0003-1023-8752 Cristina AghababyanResearch Laboratory in Biomarkers in Reproduction, Gynaecology, and Obstetrics, Research Foundation of the General University Hospital of Valencia, 46014 Valencia, Spain.ORCID 0000-0001-7611-1944 Sarai Tomás-PérezResearch Laboratory in Biomarkers in Reproduction, Gynaecology, and Obstetrics, Research Foundation of the General University Hospital of Valencia, 46014 Valencia, Spain.
Julia OtoHaemostasis, Thrombosis, Arteriosclerosis and Vascular Biology Research Group, Medical Research Institute Hospital La Fe, 46026 Valencia, Spain.ORCID 0000-0003-3963-8661 Raquel HerranzHaemostasis, Thrombosis, Arteriosclerosis and Vascular Biology Research Group, Medical Research Institute Hospital La Fe, 46026 Valencia, Spain.ORCID 0000-0002-0894-2946 Pilar MedinaHaemostasis, Thrombosis, Arteriosclerosis and Vascular Biology Research Group, Medical Research Institute Hospital La Fe, 46026 Valencia, Spain.ORCID 0000-0001-9637-5998 Martin GötteDepartment of Gynecology and Obstetrics, Münster University Hospital, 48149 Muenster, Germany.
Bárbara Andrea Mc CormackHaemostasis, Thrombosis, Arteriosclerosis and Vascular Biology Research Group, Medical Research Institute Hospital La Fe, 46026 Valencia, Spain.ORCID 0000-0002-9246-5766 Josep Marí-AlexandreResearch Laboratory in Biomarkers in Reproduction, Gynaecology, and Obstetrics, Research Foundation of the General University Hospital of Valencia, 46014 Valencia, Spain.ORCID 0000-0003-0625-4901 Juan Gilabert-EstellésResearch Laboratory in Biomarkers in Reproduction, Gynaecology, and Obstetrics, Research Foundation of the General University Hospital of Valencia, 46014 Valencia, Spain.
Instituto de Investigación Sanitaria La Fe · ESHospital General Universitario De Valencia · ESUniversity Hospital Münster · DEUniversitat de València · ES
Funding
Alexander von Humboldt Foundation post-doctoral research fellowship 2022Asociación Española Contra el Cáncer (AECC) Pre-doctoral fellowship AECC Valencia 2022Fundación para la Investigación del Hospital General Universitario de Valencia Premio FIHGUV 2021Generalitat Valenciana ACIF/2020/216Generalitat Valenciana GV/2020/200Instituto de Salud Carlos III PhD research fellowship (FI21/00171 ISCIII)Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional PI17/00495Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional PI17/01945Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional PI20/00075Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional PI22/01872Organización sin ánimo de lucro Amunt Contra el Cáncer Premio AMUNT 2022Sociedad Española de Trombosis y Hemostasia post-doctoral research fellowshipSociedad Española de Trombosis y Hemostasia Premio SETH
6 · The paper itselfAbstract
The association between the immune system and tumor progression has attracted much interest in the research community in recent years [...].
Indexed as
Immunity, InnateNeoplasmsFriendsHumansImmune System
Identifiers
PMID37108767
PMCPMC10144334
OpenAlexW4366773994
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390